Treatment of Actinic Keratosis via Destruction in Medicare Beneficiaries
JAMA Dermatology · 01.07.2026 · 162 (7) · 753
DOI: 10.1001/jamadermatol.2026.1229 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.07.2026. Verfasst von Gabriella V Alvarez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Health Services Research, University of Texas MD Anderson Cancer Center, Houston. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NCI NIH HHS.
Abstract (Originalsprache)
This cohort study evaluates the use of destruction techniques to treat actinic keratoses among Medicare beneficiaries between 2016 and 2023, both overall and by clinician type.
Autor:innen und Institutionen
- Health Services Research, University of Texas MD Anderson Cancer Center, Houston.
- Department of Dermatology, Tennessee Valley Healthcare System Veterans Affairs Medical Center, Nashville.
- Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston.
Förderung
- CSRD VA
- NCI NIH HHS
Zitieren
APA
Alvarez, G. V., Liao, K. P., Wheless, L., & Wehner, M. R. (2026). Treatment of Actinic Keratosis via Destruction in Medicare Beneficiaries. JAMA Dermatology, 162(7), 753. https://doi.org/10.1001/jamadermatol.2026.1229
Vancouver
Alvarez GV, Liao KP, Wheless L, Wehner MR. Treatment of Actinic Keratosis via Destruction in Medicare Beneficiaries. JAMA Dermatology. 2026;162(7):753. doi:10.1001/jamadermatol.2026.1229
BibTeX
@article{Alvarez2026,
author = {Alvarez, Gabriella V and Liao, Kai-Ping and Wheless, Lee and Wehner, Mackenzie R},
title = {Treatment of Actinic Keratosis via Destruction in Medicare Beneficiaries},
journal = {JAMA Dermatology},
year = {2026},
volume = {162},
number = {7},
pages = {753},
doi = {10.1001/jamadermatol.2026.1229}
}
EUVIMED